FDA Complaints Regarding Compounded Semaglutide and Tirzepatide (Since Jan 2023)

FDA Complaints Regarding Compounded Semaglutide and Tirzepatide (Since Jan 2023)

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: I would like to request electronic copies of all complaints made to the FDA concerning compounded semaglutide and tirzepatide from January 1, 2023-present
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details